0000899243-19-007526.txt : 20190313 0000899243-19-007526.hdr.sgml : 20190313 20190313161024 ACCESSION NUMBER: 0000899243-19-007526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190311 FILED AS OF DATE: 20190313 DATE AS OF CHANGE: 20190313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orford Keith CENTRAL INDEX KEY: 0001670740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 19678352 MAIL ADDRESS: STREET 1: CALITHERA BIOSCIENCES STREET 2: 343 OYSTER POINT BLVD, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-11 0 0001496671 Calithera Biosciences, Inc. CALA 0001670740 Orford Keith C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD. #200 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2019-03-11 4 S 0 1565 6.00 D 11249 D Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018. Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018. /s/ Keith Orford 2019-03-13